These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 22431963)

  • 1. A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndrome.
    Strayer DR; Carter WA; Stouch BC; Stevens SR; Bateman L; Cimoch PJ; Lapp CW; Peterson DL; ; Mitchell WM
    PLoS One; 2012; 7(3):e31334. PubMed ID: 22431963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of rintatolimod in the treatment of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME).
    Mitchell WM
    Expert Rev Clin Pharmacol; 2016 Jun; 9(6):755-70. PubMed ID: 27045557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of disease duration in a randomized Phase III trial of rintatolimod, an immune modulator for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Strayer DR; Young D; Mitchell WM
    PLoS One; 2020; 15(10):e0240403. PubMed ID: 33119613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A controlled clinical trial with a specifically configured RNA drug, poly(I).poly(C12U), in chronic fatigue syndrome.
    Strayer DR; Carter WA; Brodsky I; Cheney P; Peterson D; Salvato P; Thompson C; Loveless M; Shapiro DE; Elsasser W
    Clin Infect Dis; 1994 Jan; 18 Suppl 1():S88-95. PubMed ID: 8148460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop.
    Smith ME; Haney E; McDonagh M; Pappas M; Daeges M; Wasson N; Fu R; Nelson HD
    Ann Intern Med; 2015 Jun; 162(12):841-50. PubMed ID: 26075755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leveraging Prior Knowledge of Endocrine Immune Regulation in the Therapeutically Relevant Phenotyping of Women With Chronic Fatigue Syndrome.
    Morris MC; Cooney KE; Sedghamiz H; Abreu M; Collado F; Balbin EG; Craddock TJA; Klimas NG; Broderick G; Fletcher MA
    Clin Ther; 2019 Apr; 41(4):656-674.e4. PubMed ID: 30929860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Dietary Coenzyme Q10 Plus NADH Supplementation on Fatigue Perception and Health-Related Quality of Life in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial.
    Castro-Marrero J; Segundo MJ; Lacasa M; Martinez-Martinez A; Sentañes RS; Alegre-Martin J
    Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal seasonal influenza vaccine and a TLR-3 agonist, rintatolimod, induced cross-reactive IgA antibody formation against avian H5N1 and H7N9 influenza HA in humans.
    Overton ET; Goepfert PA; Cunningham P; Carter WA; Horvath J; Young D; Strayer DR
    Vaccine; 2014 Sep; 32(42):5490-5. PubMed ID: 25128802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment and management of chronic fatigue syndrome/myalgic encephalomyelitis: all roads lead to Rome.
    Castro-Marrero J; Sáez-Francàs N; Santillo D; Alegre J
    Br J Pharmacol; 2017 Mar; 174(5):345-369. PubMed ID: 28052319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxaloacetate Treatment For Mental And Physical Fatigue In Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Long-COVID fatigue patients: a non-randomized controlled clinical trial.
    Cash A; Kaufman DL
    J Transl Med; 2022 Jun; 20(1):295. PubMed ID: 35764955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurovascular Dysregulation and Acute Exercise Intolerance in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Randomized, Placebo-Controlled Trial of Pyridostigmine.
    Joseph P; Pari R; Miller S; Warren A; Stovall MC; Squires J; Chang CJ; Xiao W; Waxman AB; Systrom DM
    Chest; 2022 Nov; 162(5):1116-1126. PubMed ID: 35526605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-Lymphocyte Depletion in Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Fluge Ø; Rekeland IG; Lien K; Thürmer H; Borchgrevink PC; Schäfer C; Sørland K; Aßmus J; Ktoridou-Valen I; Herder I; Gotaas ME; Kvammen Ø; Baranowska KA; Bohnen LMLJ; Martinsen SS; Lonar AE; Solvang AH; Gya AES; Bruland O; Risa K; Alme K; Dahl O; Mella O
    Ann Intern Med; 2019 May; 170(9):585-593. PubMed ID: 30934066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of coenzyme Q10 plus nicotinamide adenine dinucleotide supplementation on maximum heart rate after exercise testing in chronic fatigue syndrome - A randomized, controlled, double-blind trial.
    Castro-Marrero J; Sáez-Francàs N; Segundo MJ; Calvo N; Faro M; Aliste L; Fernández de Sevilla T; Alegre J
    Clin Nutr; 2016 Aug; 35(4):826-34. PubMed ID: 26212172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Melatonin Plus Zinc Supplementation on Fatigue Perception in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Castro-Marrero J; Zaragozá MC; López-Vílchez I; Galmés JL; Cordobilla B; Maurel S; Domingo JC; Alegre-Martín J
    Antioxidants (Basel); 2021 Jun; 10(7):. PubMed ID: 34201806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Faecal microbiota transplantation (FMT) in Norwegian outpatients with mild to severe myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): protocol for a 12-month randomised double-blind placebo-controlled trial.
    Skjevling L; Goll R; Hanssen HM; Johnsen PH
    BMJ Open; 2024 Jun; 14(6):e073275. PubMed ID: 38858151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the 2-5A synthetase/RNase L antiviral pathway in a controlled clinical trial with poly(I)-poly(C12U) in chronic fatigue syndrome.
    Suhadolnik RJ; Reichenbach NL; Hitzges P; Adelson ME; Peterson DL; Cheney P; Salvato P; Thompson C; Loveless M; Müller WE
    In Vivo; 1994; 8(4):599-604. PubMed ID: 7893988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sijunzi decoction, a classical Chinese herbal formula, improves fatigue symptoms with changes in gut microbiota in chronic fatigue syndrome: A randomized, double-blind, placebo-controlled, multi-center clinical trial.
    Dai L; Liu Z; Zhou W; Zhang L; Miao M; Wang L; Hua H; Wang B; Ji G
    Phytomedicine; 2024 Jul; 129():155636. PubMed ID: 38640860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study.
    Fluge Ø; Bruland O; Risa K; Storstein A; Kristoffersen EK; Sapkota D; Næss H; Dahl O; Nyland H; Mella O
    PLoS One; 2011; 6(10):e26358. PubMed ID: 22039471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of a double-blind placebo-controlled study of the double-stranded RNA drug polyI:polyC12U in the treatment of HIV infection.
    Thompson KA; Strayer DR; Salvato PD; Thompson CE; Klimas N; Molavi A; Hamill AK; Zheng Z; Ventura D; Carter WA
    Eur J Clin Microbiol Infect Dis; 1996 Jul; 15(7):580-7. PubMed ID: 8874076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TLR3 agonists as immunotherapeutic agents.
    Nicodemus CF; Berek JS
    Immunotherapy; 2010 Mar; 2(2):137-40. PubMed ID: 20635920
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.